Revelation Biosciences (REVB) announced the Nasdaq Stock Market formally notified the company that REVB common stock will continue to be listed and traded on Nasdaq, as Revelation is in compliance with all requirements for continued listing.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on REVB:
- Revelation Biosciences Inc trading halted, news pending
- Upcoming Stock Splits This Week (January 27 to January 31) – Stay Invested
- Revelation Biosciences announces 1-for-16 reverse stock split
- Revelation Biosciences starts Phase 1b clinical study of Gemini in CKD
- Revelation Biosciences granted continued listing status on Nasdaq